HCPLive

Top Medical News Today

Study Identifies Possible Biomarkers for Bipolar Disorder
A study in Translational Psychiatry has identified three potential genes that could prove to be responsible for disturbances in mitochondrial function and DNA repair mechanisms in bipolar disorder. The genes in question – POLG, OGG1, and NDUFV2 – may open new targets for examination. The study authors themselves consider the results to be “somewhat promising.”
Canada-based researchers examined the effectiveness of opioids for the long-term management of chronic neuropathic pain and found less than encouraging results, according to a study in The Journal of Pain.
The US Food and Drug Administration today announced it will permit Quest Diagnostics' Focus Diagnostics division to market a genital swab test for herpes simplex virus type 2.
An observational study of 657 people at high risk of getting HIV infections found that Gilead's Truvada taken daily has prevented them from getting the virus. The CDC is promoting the drug regimen in a campaign called PrEP, for pre-exposure prophylaxis.
Couch potatoes, beware. According to a recent study presented at the European Society of Cardiology 2015 Congress (ESC) in London, UK, watching television for longer than five hours each day doubles the likelihood of suffering a fatal pulmonary embolism.
Cold season is officially here and for the next several months many people will be loading up on vitamin C in hopes of keeping the common, but physically draining, illness at bay. However, gorging on oranges is not necessarily the answer to making it through without the sniffles – but extra sleep might be.
New research suggests that cold weather may be an underappreciated hazard for patients with atrial fibrillation.
Children with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD) often suffer from significant bouts of depression and potentially suicide ideation, a study in the Journal of Pediatrics determined.
A recent study in the Journal of Pain Research found that placing an electrical stimulation device properly doesn’t necessarily increase the pain threshold for health patients subjected to transcutaneous electrical nerve stimulation (TENS). The finding is important because TENS is among many nonpharmacological interventions for pain around which clinical opinion on effectiveness is split.

Features

Resources for Your Patients

Click here for the latest hepatitis C news and updates for patients

Most Popular

Recent Published Journal

$vacMongoViewPlus$ $vAR$